Your browser doesn't support javascript.
loading
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC).
Abou-Alfa, Ghassan K; Yen, Chia-Jui; Hsu, Chih-Hung; O'Donoghue, Joseph; Beylergil, Volkan; Ruan, Shutian; Pandit-Taskar, Neeta; Gansukh, Bolorsukh; Lyashchenko, Serge K; Ma, Jennifer; Wan, Peter; Shao, Yu-Yun; Lin, Zhong-Zhe; Frenette, Catherine; O'Neil, Bert; Schwartz, Lawrence; Smith-Jones, Peter M; Ohtomo, Toshihiko; Tanaka, Takayoshi; Morikawa, Hideo; Maki, Yuko; Ohishi, Norihisa; Chen, Ya-Chi; Agajanov, Tamara; Boisserie, Frederic; Di Laurenzio, Laura; Lee, Ray; Larson, Steven M; Cheng, Ann-Lii; Carrasquilo, Jorge A.
Afiliación
  • Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. abou-alg@mskcc.org.
  • Yen CJ; Weill Cornell Medical College, New York, NY, USA. abou-alg@mskcc.org.
  • Hsu CH; National Cheng-Kung University Hospital, Tainan, Taiwan, Republic of China.
  • O'Donoghue J; National Taiwan University Hospital, Taipei, Taiwan, Republic of China.
  • Beylergil V; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Ruan S; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Pandit-Taskar N; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Gansukh B; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Lyashchenko SK; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Ma J; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Wan P; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Shao YY; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Lin ZZ; National Taiwan University Hospital, Taipei, Taiwan, Republic of China.
  • Frenette C; National Taiwan University Hospital, Taipei, Taiwan, Republic of China.
  • O'Neil B; Scripps Clinic, San Diego, CA, USA.
  • Schwartz L; Indiana University Simon Cancer Center, Indianapolis, IN, USA.
  • Smith-Jones PM; Columbia University Hospital, New York, USA.
  • Ohtomo T; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Tanaka T; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.
  • Morikawa H; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.
  • Maki Y; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.
  • Ohishi N; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.
  • Chen YC; Chugai Pharmaceutical Co. Ltd., Tokyo, Japan.
  • Agajanov T; Translational and Clinical Research Center, Hoffmann-La Roche Inc., New York, USA.
  • Boisserie F; Translational and Clinical Research Center, Hoffmann-La Roche Inc., New York, USA.
  • Di Laurenzio L; Translational and Clinical Research Center, Hoffmann-La Roche Inc., New York, USA.
  • Lee R; Translational and Clinical Research Center, Hoffmann-La Roche Inc., New York, USA.
  • Larson SM; Translational and Clinical Research Center, Hoffmann-La Roche Inc., New York, USA.
  • Cheng AL; Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • Carrasquilo JA; Weill Cornell Medical College, New York, NY, USA.
Cancer Chemother Pharmacol ; 79(2): 421-429, 2017 Feb.
Article en En | MEDLINE | ID: mdl-28120036

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Glipicanos / Anticuerpos Monoclonales Humanizados / Neoplasias Hepáticas Idioma: En Revista: Cancer Chemother Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Hepatocelular / Glipicanos / Anticuerpos Monoclonales Humanizados / Neoplasias Hepáticas Idioma: En Revista: Cancer Chemother Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos